bioRxivMolecular BiologyPreprint
Development of a Bacterial Colorimetric Reporter System for Functional Screening of SARS-Cov-2 Main Protease Inhibitors Using Plant Preparations (juices): A Proof-of-Concept Study
Shaza S. IssaiD, Andrew А. ZelinskyiD, Haidar J. FayoudiD, Roman R. ZhidkiniD, Tatiana V. MatveevaiD
Abstract
SARS-CoV-2 main protease (Mpro) is essential for viral polyprotein processing and represents a prime target for antiviral drug discovery. However, most available screening strategies rely on biochemical and computational approaches that lack the biological context of living cells, or costly mammalian-cell based models. Therefore, there remains a shortage of simple and biosafe cellular models enabling rapid, functional screening of potential Mpro inhibitors, particularly those derived from natural sources and in urgent situations such as the COVID-19 pandemic. In this study, a bacterial colorimetric reporter system was developed that directly links SARS-CoV-2 Mpro activity to {beta}-galactosidase function in Escherichia coli. To the best of our knowledge, the developed system represents the first bacterial colorimetric model for direct monitoring of SARS-CoV-2 Mpro inhibition in living cells. The system enables real-time visual detection of protease inhibition on X-gal-containing medium and provides a cost-effective, biologically relevant, biosafe alternative to existing screening assays. Functional validation was performed using pomegranate juice as a representative natural inhibitor source. The system provides a simple, scalable, and biosafe platform for the primary screening of antiviral candidates, including phytochemicals, under standard laboratory conditions.
- organism: bacteria (other)
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Gain-of-function assay for SARS-CoV-2 Mpro inhibition in living cells
S. A. Moghadasi, J. T. Becker, … R. Harris·bioRxiv·Nov 9, 2020
- Phycobilins as potent food bioactive broad-spectrum inhibitor compounds against Mpro and PLpro of SARS-CoV-2 and other coronaviruses: A preliminary Study
B. Pendyala, A. Patras, C. Dash·bioRxiv·Nov 21, 2020
- A genetic trap in yeast for inhibitors of SARS-CoV-2 main protease
Hanna Alalam, Sunniva Sigurdardóttir, … Per Sunnerhagen·mSystemsPeer-reviewed·Nov 23, 2021
- An expedited approach towards the rationale design of non-covalent SARS-CoV-2 main protease inhibitors with in vitro antiviral activity
N. Kitamura, M. D. Sacco, … J. Wang·bioRxiv·Dec 19, 2020
- Structure-based identification of naphthoquinones and derivatives as novel inhibitors of main protease Mpro and papain-like protease PLpro of SARS-CoV-2
L. H. Santos, T. Kronenberger, … R. Ferreira·bioRxiv·Jan 5, 2022
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
C. Ma, M. D. Sacco, … J. Wang·Cell ResearchPeer-reviewed·Jun 15, 2020